Clinical inertia in management of T2DM

被引:62
|
作者
Zafar, Azhar [1 ]
Davies, M. [2 ]
Azhar, A. [3 ]
Khunti, Kamlesh
机构
[1] Univ Leicester, Div Primary Care Diabet & Cardiovasc Med, Dept Hlth Sci, Leicester LE1 6TP, Leics, England
[2] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 6TP, Leics, England
[3] Milton Keynes Dist Gen Hosp, Milton Keynes, Bucks, England
关键词
Clinical inertia; Managment of T2DM; Primary care;
D O I
10.1016/j.pcd.2010.07.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes is highly prevalent and serious chronic debilitating disease and reported to be the fourth main cause of death in Europe. Despite extensive evidence of benefits of tight glycemic control, large proportions of people with diabetes do not achieve target glycemic control. One major reason for this is clinical inertia which is "recognising the problem but failure to act" by health care professionals in primary care. The key issues in the management of people with T2DM include early detection of problems, realistic goal setting, improved patient adherence, better knowledge and understanding of pharmacotherapeutic treatment options and prompt intervention. Health care professionals must need to overcome clinical inertia and need to intensify therapy in an appropriate and timely manner. (C) 2010 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:203 / 207
页数:5
相关论文
共 50 条
  • [21] Personalized medicine- future of diagnosis and management of T2DM
    Verma, Sushma
    Rizvi, Saliha
    Abbas, Mohd
    Raza, Tasleem
    Mahdi, Farzana
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (04) : 2425 - 2430
  • [22] Obesity and T2DM in youth
    Weiss, Ram
    Caprio, Sonia
    [J]. ENDOCRINE RESEARCH, 2008, 33 (1-2) : 59 - 72
  • [23] T2DM: Why Epigenetics?
    Fradin, Delphine
    Bougneres, Pierre
    [J]. JOURNAL OF NUTRITION AND METABOLISM, 2011, 2011
  • [24] PAEDIATRIC ENDOCRINOLOGY Transatlantic differences in the management of T2DM in youth
    Danne, Thomas
    Kordonouri, Olga
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2013, 9 (05) : 263 - 264
  • [25] Vardenafil in men with T2DM
    Clemens Thoma
    [J]. Nature Reviews Urology, 2016, 13 (3) : 126 - 126
  • [26] Targeting hyperglucagonaemia in T2DM
    Starling S.
    [J]. Nature Reviews Endocrinology, 2022, 18 (7) : 393 - 393
  • [27] Intermittent Fasting as Part of the Management for T2DM: from Animal Models to Human Clinical Studies
    Munoz-Hernandez, Liliana
    Marquez-Lopez, Ziomara
    Mehta, Roopa
    Aguilar-Salinas, Carlos Alberto
    [J]. CURRENT DIABETES REPORTS, 2020, 20 (04)
  • [28] Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients
    Yan, Xueyu
    Si, Jinglei
    Zhong, Fangjie
    Wu, Yanjun
    Jiang, Qinyang
    Guo, Yafen
    Yang, Xiurong
    Liang, Jing
    Lan, Ganqiu
    [J]. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (02) : 236 - 244
  • [29] FERTILITY IN T1DM AND T2DM PATIENTS
    Ben Haroush, A.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A12 - A12
  • [30] Intermittent Fasting as Part of the Management for T2DM: from Animal Models to Human Clinical Studies
    Liliana Muñoz-Hernández
    Ziomara Márquez-López
    Roopa Mehta
    Carlos Alberto Aguilar-Salinas
    [J]. Current Diabetes Reports, 2020, 20